Posts

Novartis spends €2.7 billion on acquiring MorphoSys

The recent buzz surrounding a potential bidding war for the cancer specialist Mo...

Verekitug by Upstream Bio for Rhinosinusitis: Likelihoo...

Verekitug is under clinical development by Upstream Bio and currently in Phase I...

Tapotoclax by Amgen for Myelodysplastic Syndrome: Likel...

Tapotoclax is under clinical development by Amgen and currently in Phase I for M...

Tapotoclax by Amgen for Chronic Myelomonocytic Leukemia...

Tapotoclax is under clinical development by Amgen and currently in Phase I for C...

Vorolanib by EyePoint Pharmaceuticals for Diabetic Macu...

Vorolanib is under clinical development by EyePoint Pharmaceuticals and currentl...

Monoclonal Antibody Conjugate 3 to Target EGFR for Onco...

Monoclonal Antibody Conjugate 3 to Target EGFR for Oncology is under clinical de...

(Edetate disodium + ethyl alcohol + minocycline hydroch...

(Edetate disodium + ethyl alcohol + minocycline hydrochloride) is under clinical...

(Edetate disodium + ethyl alcohol + minocycline hydroch...

(Edetate disodium + ethyl alcohol + minocycline hydrochloride) is under clinical...

(Edetate disodium + ethyl alcohol + minocycline hydroch...

(Edetate disodium + ethyl alcohol + minocycline hydrochloride) is under clinical...

AFM-24I by Affimed for Metastatic Hepatocellular Carcin...

AFM-24I is under clinical development by Affimed and currently in Phase II for M...

INCB-57643 by Incyte for Myelofibrosis: Likelihood of A...

INCB-57643 is under clinical development by Incyte and currently in Phase II for...

STAT+: Years into an addiction crisis, a med school lec...

A university in Florida has been criticized for allowing a lecture that conveyed...

The GLP-1 panic is alive and well

The need-to-know in biotech this morning: —The arrival of Scion Life Sciences —G...

STAT+: Pharmalittle: We’re reading about worries over a...

Eli Lilly is worried a deal to expand production of Novo Nordisk's weight-loss d...

STAT+: RayzeBio co-founder, industry veterans launch ne...

Three biotech VC veterans, including one of the co-founders of radiopharma succe...

STAT+: AI can speed up drug discovery but don’t expect ...

AI models can help speed up some parts of the drug development process but exper...